Web of Science: 2 cites, Scopus: 2 cites, Google Scholar: cites,
Kidney disease in adults with Prader-Willi syndrome : international cohort study and systematic literature review
van Abswoude, Denise H. (University Medical Center Rotterdam)
Pellikaan, Karlijn (University Medical Center Rotterdam)
Nguyen, Naomi (University Medical Center Rotterdam)
Rosenberg, Anna G. W. (University Medical Center Rotterdam)
Davidse, Kirsten (University Medical Center Rotterdam)
Hoekstra, Franciska M. E. (University Medical Center Rotterdam)
Rood, Ilse M. (Radboud University Medical Center (Nijmegen, Holanda))
Poitou, Christine (Sorbonne Université)
Grugni, Graziano (Istituto di Ricovero e Cura a Carattere Scientifico (Piancavallo, Itàlia))
Høybye, Charlotte (Karolinska University Hospital and Karolinska Institutet (Suècia))
Markovic, Tania P. (University of Sydney)
Caixàs i Pedragós, Assumpta (Universitat Autònoma de Barcelona. Departament de Medicina)
Crinò, Antonino (Fondazione Policlinico Universitario A. Gemelli (Roma, Itàlia))
van den Berg, Sjoerd A. A. (University Medical Center Rotterdam)
van der Lely, Aart J. (University Medical Center Rotterdam)
De Graaff, Laura C. G (University Medical Center Rotterdam)

Data: 2023
Resum: Prader-Willi syndrome (PWS) is a rare, complex, genetic disorder characterized by hyperphagia, hypotonia, delayed psychomotor development, low muscle mass and hypothalamic dysfunction. Adults with PWS often have obesity, hypertension and type 2 diabetes mellitus (DM2), known risk factors for cardiovascular disease (CVD) and chronic kidney disease (CKD). Early symptoms of CVD and CKD may be masked by intellectual disability and inability to express physical complaints. Furthermore, kidney diseases are often asymptomatic. Therefore, renal and cardiovascular disease might be missed in patients with PWS. Microalbuminuria is an early sign of microvascular damage in the kidneys and other vascular beds. Therefore, we screened our adult PWS cohort for the presence of elevated urinary albumin and (micro)albuminuria. We retrospectively collected anthropometric measurements, blood pressure, medical history, medication use, urine dipstick and biochemical measurements form electronic patient files. In addition, we performed a systematic literature review on kidney disease in PWS. We included 162 adults with genetically confirmed PWS (56% male, median age 28 years), of whom 44 (27%) had DM2. None had known CVD. All subjects had normal estimated glomerular filtration rate (eGFR) according to non-PWS reference intervals. Elevated urinary albumin or (micro)albuminuria was present in 28 (18%); 19 out of 75 (25%) had an increased urinary albumin-to-creatinine ratio (UACR) and 10 out of 57 (18%) had an increased urinary protein-to-creatinine ratio. Elevated urinary albumin was present at a young age (median age 26 (IQR 24-32) years) and was associated with an significantly higher BMI and LDL-cholesterol levels and higher prevalence of DM2, hypertension and dyslipidemia than those with normal UACR (p =0. 027, p =0. 019, p <0. 001, p <0. 001, p =0. 011 and respectively). Upon screening, one in every five adults with PWS had increased urinary albumin or (micro)albuminuria, early signs of microvascular disease. All had normal eGFR, according to non-PWS reference intervals, and none had a formal diagnosis of CVD. As muscle mass is low in PWS, creatinine levels and eGFR may be spuriously normal. Urinalysis in this patient group can be used as a screening tool for microvascular (kidney) disease. We propose an algorithm for the detection and management of microvascular disease in adults with PWS.
Drets: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Llengua: Anglès
Document: Article ; recerca ; Versió publicada
Matèria: Prader-Willi Syndrome ; Kidney function tests ; Proteinuria ; Urine tract infections ; Cardiovascular disease ; Kidney disease
Publicat a: Frontiers in endocrinology, Vol. 14 (july 2023) , ISSN 1664-2392

DOI: 10.3389/fendo.2023.1168648
PMID: 37547314


19 p, 1.1 MB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats

 Registre creat el 2024-11-09, darrera modificació el 2025-03-08



   Favorit i Compartir